Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial

BACKGROUND: Increasing buprenorphine/naloxone (B/N) access for opioid use disorder (OUD) is essential yet ensuring adherence and preventing diversion remains challenging. This study examines the feasibility, usability, and acceptability of MySafeRx, a mobile platform integrating motivational coachin...

Descripción completa

Detalles Bibliográficos
Autores principales: Janzow, Grace E., Harding, Cassandra, Flores, Michael, Borodovsky, Jacob, Steinkamp, Jackson, Marsch, Lisa A., Schuman-Olivier, Zev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949338/
https://www.ncbi.nlm.nih.gov/pubmed/36845988
http://dx.doi.org/10.1016/j.dadr.2022.100045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949338/
https://www.ncbi.nlm.nih.gov/pubmed/36845988
http://dx.doi.org/10.1016/j.dadr.2022.100045

Ejemplares similares